Technical Analysis for BJDX - Bluejay Diagnostics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | 6.00% | |
| Crossed Above 20 DMA | Bullish | 0.02% | |
| Gapped Up | Strength | 0.02% | |
| Spinning Top | Other | 8.16% | |
| NR7 | Range Contraction | 8.16% | |
| Narrow Range Bar | Range Contraction | 8.16% |
| Alert | Time |
|---|---|
| 20 DMA Support | 1 day ago |
| 10 DMA Support | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Down 2 % | 1 day ago |
Get a Trading Assistant
- Earnings date: 12/14/2023
Bluejay Diagnostics, Inc. Description
Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Cancer Clinical Medicine Infectious Diseases Inflammation Biomarkers Allergy Allergic Conjunctivitis Chemical Pathology Congestive Heart Failure Sepsis Conjunctivitis Lyme Disease Tick Borne Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.9799 |
| 52 Week Low | 0.39 |
| Average Volume | 46,069 |
| 200-Day Moving Average | 2.30 |
| 50-Day Moving Average | 0.60 |
| 20-Day Moving Average | 0.53 |
| 10-Day Moving Average | 0.52 |
| Average True Range | 0.07 |
| RSI (14) | 47.09 |
| ADX | 33.48 |
| +DI | 13.50 |
| -DI | 21.36 |
| Chandelier Exit (Long, 3 ATRs) | 0.40 |
| Chandelier Exit (Short, 3 ATRs) | 0.60 |
| Upper Bollinger Bands | 0.57 |
| Lower Bollinger Band | 0.48 |
| Percent B (%b) | 0.54 |
| BandWidth | 18.47 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.03 |
| MACD Histogram | 0.0061 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.63 | ||||
| Resistance 3 (R3) | 0.62 | 0.59 | 0.61 | ||
| Resistance 2 (R2) | 0.59 | 0.56 | 0.59 | 0.60 | |
| Resistance 1 (R1) | 0.56 | 0.55 | 0.54 | 0.56 | 0.60 |
| Pivot Point | 0.52 | 0.52 | 0.51 | 0.52 | 0.52 |
| Support 1 (S1) | 0.49 | 0.50 | 0.48 | 0.50 | 0.46 |
| Support 2 (S2) | 0.46 | 0.48 | 0.46 | 0.46 | |
| Support 3 (S3) | 0.43 | 0.46 | 0.45 | ||
| Support 4 (S4) | 0.43 |
